Xigris and Digoxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xigris (drotrecogin alfa (activated)) and Digoxin (digoxin). Common drug interactions include catheter site haemorrhage among females and brain herniation among males.

The phase IV clinical study analyzes what interactions people have when they take Xigris and Digoxin. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Xigris?

Xigris has active ingredients of drotrecogin alfa (activated). eHealthMe is studying from 3,542 Xigris users. Check the latest studies of Xigris.

What is Digoxin?

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.



On Jul, 25, 2026

26 people who take Xigris and Digoxin together, and have interactions are studied.

Xigris and Digoxin drug interactions.

What are the common drug interactions of Xigris and Digoxin, by gender? *:

female:

  1. Catheter site haemorrhage (bleeding at catheter site)
  2. Cerebral infarction (less blood supply to brain resulting tissue damage)
  3. Escherichia infection (bacterial infection by escherichia coli)
  4. Platelet count decreased
  5. Proteus infection (proteus can cause urinary tract infections)
  6. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Vaginal haemorrhage (vaginal bleeding)
  9. Alanine aminotransferase increased
  10. Arterial haemorrhage

male:

  1. Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
  2. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  3. Blood bilirubin increased
  4. Blood creatinine increased
  5. Cardiac arrest
  6. Cardiovascular disorder (heart diseases)
  7. Circulatory collapse
  8. Colonic polyp (extra part of colon tissue grow in intestine)
  9. Congestive cardiomyopathy (weakening of heart muscle)
  10. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

What are the common drug interactions of Xigris and Digoxin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Catheter site haemorrhage (bleeding at catheter site)
  2. Vaginal haemorrhage (vaginal bleeding)
  3. Arterial haemorrhage
  4. Blood pressure decreased
  5. Heart rate decreased
  6. Intra-abdominal haemorrhage (intra-abdominal bleeding)
  7. Platelet count decreased

40-49:

n/a

50-59:

  1. Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
  2. Cerebral infarction (less blood supply to brain resulting tissue damage)
  3. Escherichia infection (bacterial infection by escherichia coli)
  4. Intraventricular haemorrhage (intraventricular bleeding)
  5. Proteus infection (proteus can cause urinary tract infections)
  6. Pyrexia (fever)
  7. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  8. Thrombocytopenia (decrease of platelets in blood)
  9. Acute respiratory distress syndrome
  10. Ascites (accumulation of fluid in the abdominal cavity)

60+:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. General physical health deterioration (weak health status)
  4. Haemoglobin decreased
  5. Hepatic failure (liver failure)
  6. Hypoglycaemia (deficiency of glucose in the bloodstream)
  7. Hypoxia (low oxygen in tissues)
  8. International normalised ratio increased
  9. Lactic acidosis (low ph in body tissues)
  10. Multiple injuries

What are the existing conditions these people have? *

  1. Sepsis (a severe blood infection that can lead to organ failure and death): 10 people, 38.46%
  2. Septic Shock (shock due to blood infection): 6 people, 23.08%
  3. Sedation: 2 people, 7.69%
  4. Neuromuscular Blockade: 2 people, 7.69%
  5. Hyperglycemia (high blood sugar): 2 people, 7.69%
  6. Cardiac Disorder: 2 people, 7.69%
  7. Arrhythmias (irregular heartbeat): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Xigris and Digoxin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Xigris and Digoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xigris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Digoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xigris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Digoxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on drotrecogin alfa (activated) and digoxin (the active ingredients of Xigris and Digoxin, respectively), and Xigris and Digoxin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: